Literature DB >> 26378607

Molecular epidemiology and surveillance of circulating rotavirus and adenovirus in Congolese children with gastroenteritis.

Gontran Mayindou1,2, Berge Ngokana1,2, Anissa Sidibé1,2, Victoire Moundélé1,2, Felix Koukouikila-Koussounda1,2, Jeannhey Christevy Vouvoungui1,2, Sylvie Kwedi Nolna1,3, Thirumalaisamy P Velavan1,4, Francine Ntoumi1,2,4.   

Abstract

Infectious Diarrhea caused by rotavirus and adenovirus, is a leading cause of death in children in sub-Sahara Africa but there is limited published data on the diverse rotavirus genotypes and adenovirus serotypes circulating in the Republic of Congo. In this study, we investigated the prevalence of severe diarrhea caused by rotavirus A (RVA) and Adenovirus serotype 40 and 41 in Congolese children hospitalized with severe gastroenteritis. Stool samples were collected from 655 Congolese children less than 60 months of age hospitalized with acute gastroenteritis between June 2012 and June 2013. Rotavirus and adenovirus antigens were tested using commercially available ELISA kits and the RVA G- and P- genotypes were identified by seminested multiplex RT-PCR. Three hundred and four (46.4%) children were tested positive for RVA. Adenovirus infection was found in 5.5% of the 564 tested children. Rotavirus infection was frequently observed in children between 6-12 months (55.9%). The dry season months recorded increased RVA infection while no seasonality of adenovirus infection was demonstrated. The most common RVA genotypes were G1 (57.5%), G2 (6.4%), G1G2 mixture (15.5%), P[8] (58%), P[6] (13.2%), and P[8]P[6] mixture (26%). Additionally, the genotype G12P[6] was significantly associated with increased vomiting. This first study on Congolese children demonstrates a high prevalence and clinical significance of existing rotavirus genotypes. Adenovirus prevalence is similar to that of other Central African countries. This baseline epidemiology and molecular characterization study will contribute significantly to the RVA surveillance after vaccine implementation in the country.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  Republic of Congo; adenovirus; gastroenteritis; genotypes

Mesh:

Substances:

Year:  2015        PMID: 26378607     DOI: 10.1002/jmv.24382

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  13 in total

1.  Diversity of enteric and non-enteric human adenovirus strains in Brazil, 2006-2011.

Authors:  Ellen Viana de Souza; Yasmin França Viana Pires de Souza; Roberta Salzone Medeiros; Lais Sampaio de Azevedo; Talita Gonçalves Aires de Queiroz; Rodrigo Lopes Sanz-Duro; Robson Dos Santos Souza Marinho; Shirley Vasconcelos Komninakis; Maria do Carmo Sampaio Tavares Timenetsky; Adriana Luchs
Journal:  Arch Virol       Date:  2021-01-18       Impact factor: 2.574

2.  Molecular-Genetic Characterization of Human Rotavirus A Strains Circulating in Moscow, Russia (2009-2014).

Authors:  Victoria Kiseleva; Evgeny Faizuloev; Elena Meskina; Anna Marova; Alexey Oksanich; Tatiana Samartseva; Georgy Bakhtoyarov; Natalia Bochkareva; Nikolay Filatov; Andrey Linok; Yulia Ammour; Vitaly Zverev
Journal:  Virol Sin       Date:  2018-07-30       Impact factor: 4.327

3.  Longitudinal quantification of adenovirus neutralizing responses in Zambian mother-infant pairs: Impact of HIV-1 infection and its treatment.

Authors:  Sara R Privatt; Brianna L Bullard; Eric A Weaver; Charles Wood; John T West
Journal:  Vaccine       Date:  2019-08-01       Impact factor: 3.641

4.  P[8] and P[4] Rotavirus Infection Associated with Secretor Phenotypes Among Children in South China.

Authors:  Xu-Fu Zhang; Yan Long; Ming Tan; Ting Zhang; Qiong Huang; Xi Jiang; Wen-Fang Tan; Jian-Dong Li; Gui-Fang Hu; Shixing Tang; Ying-Chun Dai
Journal:  Sci Rep       Date:  2016-10-06       Impact factor: 4.379

5.  From Lab to Lake - Evaluation of Current Molecular Methods for the Detection of Infectious Enteric Viruses in Complex Water Matrices in an Urban Area.

Authors:  Mats Leifels; Ibrahim Ahmed Hamza; Marion Krieger; Michael Wilhelm; Martin Mackowiak; Lars Jurzik
Journal:  PLoS One       Date:  2016-11-23       Impact factor: 3.240

6.  Characterization of rotavirus infection in children with acute gastroenteritis in Bengo province, Northwestern Angola, prior to vaccine introduction.

Authors:  Carolina Gasparinho; João Piedade; Maria Clara Mirante; Cristina Mendes; Carlos Mayer; Susana Vaz Nery; Miguel Brito; Claudia Istrate
Journal:  PLoS One       Date:  2017-04-19       Impact factor: 3.240

7.  Temporal distribution of gastroenteritis viruses in Ouagadougou, Burkina Faso: seasonality of rotavirus.

Authors:  Nafissatou Ouedraogo; Stephanie Moustapha Tomba Ngangas; Isidore Juste Ouindguèta Bonkoungou; Aissatou Bénéwendé Tiendrebeogo; Kuan Abdoulaye Traore; Idrissa Sanou; Alfred Sababénédjo Traore; Nicolas Barro
Journal:  BMC Public Health       Date:  2017-03-21       Impact factor: 3.295

8.  Genetic analysis of Ghanaian G1P[8] and G9P[8] rotavirus A strains reveals the impact of P[8] VP4 gene polymorphism on P-genotyping.

Authors:  Susan Afua Damanka; Chantal Ama Agbemabiese; Francis Ekow Dennis; Belinda Larteley Lartey; Theophilus Korku Adiku; Christabel Chika Enweronu-Laryea; George Enyimah Armah
Journal:  PLoS One       Date:  2019-06-26       Impact factor: 3.240

9.  Prevalence and Genetic Diversity of Enteric Viruses in Children with Diarrhea in Ouagadougou, Burkina Faso.

Authors:  Nafissatou Ouédraogo; Jérôme Kaplon; Isidore Juste O Bonkoungou; Alfred Sababénédjo Traoré; Pierre Pothier; Nicolas Barro; Katia Ambert-Balay
Journal:  PLoS One       Date:  2016-04-19       Impact factor: 3.240

10.  Evolution in fecal bacterial/viral composition in infants of two central African countries (Gabon and Republic of the Congo) during their first month of life.

Authors:  Lionel Brazier; Eric Elguero; Claudine Kombila Koumavor; Nicolas Renaud; Franck Prugnolle; Frédéric Thomas; Simon Ategbo; Moyen Engoba; Eric M Leroy; Patrick Durand; François Renaud; Pierre Becquart
Journal:  PLoS One       Date:  2017-10-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.